NEUBERGER BERMAN ALTERNATIVE FUNDS Form N-PX

NEUBERGER BERMAN ALTERNATIVE FUNDS Form N-PX

SECURITIES AND EXCHANGE COMMISSION FORM N-PX Annual report of proxy voting record of registered management investment companies filed on Form N-PX Filing Date: 2017-08-24 | Period of Report: 2017-06-30 SEC Accession No. 0000898432-17-000842 (HTML Version on secdatabase.com) FILER NEUBERGER BERMAN ALTERNATIVE FUNDS Mailing Address Business Address 1290 AVENUE OF THE 1290 AVENUE OF THE CIK:1317474| IRS No.: 000000000 | State of Incorp.:DE | Fiscal Year End: 1031 AMERICAS AMERICAS Type: N-PX | Act: 40 | File No.: 811-21715 | Film No.: 171048680 NEW YORK NY 10104 NEW YORK NY 10104 (212) 476-8800 Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document As filed with the Securities and Exchange Commission on August 24, 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-PX Annual Report of Proxy Voting Record of Registered Management Investment Company Investment Company Act file number: 811-21715 NEUBERGER BERMAN ALTERNATIVE FUNDS (Exact Name of the Registrant as Specified in Charter) c/o Neuberger Berman Investment Advisers LLC 1290 Avenue of the Americas New York, New York 10104-0002 (Address of Principal Executive Offices – Zip Code) Registrant's telephone number, including area code: (212) 476-8800 Robert Conti Chief Executive Officer and President Neuberger Berman Alternative Funds c/o Neuberger Berman Investment Advisers LLC 1290 Avenue of the Americas New York, New York 10104-0002 Arthur C. Delibert, Esq. K&L Gates LLP 1601 K Street, N.W. Washington, D.C. 20006-1600 (Names and Addresses of agents for service) Date of fiscal year end: October 31 Date of reporting period: July 1, 2016 to June 30, 2017 Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles. A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained on Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 100 F Street, NE, Washington DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507. Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Item 1. Proxy Voting Record. Neuberger Berman Hedged Option Premium Strategy Fund There were no matters relating to a portfolio security considered at any shareholder meeting held from the inception date to June 30, 2017 with respect to which the Fund was entitled to vote. Neuberger Berman Risk Balanced Commodity Strategy Fund There were no matters relating to a portfolio security considered at any shareholder meeting held from July 1, 2016 to June 30, 2017 with respect to which the Fund was entitled to vote. Neuberger Berman U.S. Equity Index PutWrite Strategy Fund There were no matters relating to a portfolio security considered at any shareholder meeting held from the inception date to June 30, 2017 with respect to which the Fund was entitled to vote. NPX Proxy Voting Record Registrant : Neuberger Berman Alternative Funds Fund Name : Neuberger Berman Absolute Return Multi-Manager Fund 07/01/2016 - 06/30/2017 Alexion Pharmaceuticals Ticker Security ID: Meeting Date Meeting Status ALXN CUSIP 15351109 05/10/2017 Voted Meeting Type Country of Trade Annual United States Issue No. Description Proponent Mgmt Vote CastFor/ Rec Agnst Mgmt 1 Election Of Director: Felix J Baker Mgmt For Abstain Against 2 Election Of Director: David R Brennan Mgmt For Abstain Against 3 Election Of Director: M Michele Burns Mgmt For Abstain Against 4 Election Of Director: Christopher J Mgmt For Abstain Against Coughlin 5 Election Of Director: Ludwig N Hantson Mgmt For Abstain Against 6 Election Of Director: John T Mollen Mgmt For Abstain Against 7 Election Of Director: R Douglas Norby Mgmt For Abstain Against 8 Election Of Director: Alvin S Parven Mgmt For Abstain Against 9 Election Of Director: Andreas Rummelt Mgmt For Abstain Against 10 Election Of Director: Ann M Veneman Mgmt For Abstain Against 11 To Approve Alexions 2017 Incentive Plan Mgmt For Abstain Against 12 Ratification Of Appointment By The Board Mgmt For Abstain Against Of Directors Of Pricewaterhousecoopersllp As Alexion'S Independent Registered Public Accounting Firm 13 Approval Of A Non Binding Adivsory Vote Mgmt For Abstain Against Of The 2016 Compensation Paid To Alexion'S Named Executive Officers Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document 14 To Recommend, By Non Binding Vote, The Mgmt For Abstain Against Frequency Of Future Advisory Votes On The Executive Compensation 15 To Request The Board Implement Mgmt For Abstain Against Confidential Shareholder Voting On Executive Pay Matters Align Technology Ticker Security ID: Meeting Date Meeting Status ALGN CUSIP 016255101 05/17/2017 Voted Meeting Type Country of Trade Annual United States Issue No. Description Proponent Mgmt Vote CastFor/ Rec Agnst Mgmt 1 Election Of Director: Joseph M Hogan Mgmt For Abstain Against 2 Election Of Director: Joseph Lacob Mgmt For Abstain Against 3 Election Of Directorr: C Raymond Larkin Jr Mgmt For Abstain Against 4 Election Of Director : George J Morrow Mgmt For Abstain Against 5 Election Of Director: Thomas M Prescott Mgmt For Abstain Against 6 Election Of Director: Andrew L Saia Mgmt For Abstain Against 7 Election Of Director: Greg J Santora Mgmt For Abstain Against 8 Election Of Director: Susan E Siegel Mgmt For Abstain Against 9 Election Of Director: Warren S Thaler Mgmt For Abstain Against 10 Proposal To Ratify To The Appointment Of Mgmt For Abstain Against Pricwaterhousecoopers Llp As Align Technology Inc'S Independent Registered Public Accountings For The Fiscal Year 12/ 31/2017 11 Advisory Vote To Approve The Named Mgmt For Abstain Against Executive Officer Compensation 12 Advisory Vote On The Frequency Of Mgmt For Abstain Against Holding An Advisory Vote On Executive Compensation Allscripts Healthcare Solutions Inc Ticker Security ID: Meeting Date Meeting Status MDRX CUSIP 01988P108 05/22/2017 Voted Meeting Type Country of Trade Annual United States Issue No. Description Proponent Mgmt Vote CastFor/ Rec Agnst Mgmt 1 Election Of Director: Mara G Aspinall Mgmt For Abstain Against 2 Election Of Director: Paul M Black Mgmt For Abstain Against 3 Election Of Director; P Gregory Garrison Mgmt For Abstain Against 4 Election Of Director: Jonathan J Judge Mgmt For Abstain Against 5 Election Of Director: Michael A Klayko Mgmt For Abstain Against 6 Election Of Director: Yancey L Spruill Mgmt For Abstain Against 7 Election Of Director: Dave B Stevens Mgmt For Abstain Against 8 Election Of Director: David D Stevens Mgmt For Abstain Against 9 Election Of Director: Ralph H Thurman Mgmt For Abstain Against 10 To Approve An Amendment And Mgmt For Abstain Against Restatement Of The Allscripts Healthcare Solutions Inc 2011 Stock Incentive Plan To, Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Among Other Things, Increase The Number Of Shares Available For Grant Thereunder 11 To Ratify The Appointment Of Grant Mgmt For Abstain Against Thornton Llp As The …(Due To Space Limits See Proxy Statement For Full Proposal) 12 To Approve, On An Advisory Basis, The Mgmt For Abstain Against Companys Named Executive Officer Compensation 13 To Approve, On An Advisory Basis, The Mgmt For Abstain Against Frequency Of The Advisory Vote On The Companys Named Executive Officer Compensation Biogen Inc Ticker Security ID: Meeting Date Meeting Status BIIB CUSIP 09062X103 06/07/2017 Voted Meeting Type Country of Trade Annual United States Issue No. Description Proponent Mgmt Vote CastFor/ Rec Agnst Mgmt 1 Election Of Director: Alexander Mgmt For For For J. Denner 2 Election Of Director: Caroline D. Mgmt For For For Dorsa 3 Election Of Director: Nancy L. Mgmt For For For Leaming 4 Election Of Director: Richard C. Mgmt For For For Mulligan 5 Election Of Director: Robert W. Mgmt For For For Pangia 6 Election Of Director: Stelios Mgmt For For For Papadopoulos 7 Election Of Director: Brian S. Mgmt For For For Posner 8 Election Of Director: Eric K. Mgmt For For For Rowinsky 9 Election Of Director: Lynn Mgmt For For For Schenk 10 Election Of Director: Stephen A. Mgmt For For For Sherwin 11 Election Of Director: Michel Mgmt For For For Vounatsos 12 To Ratify The Selection Of Mgmt For For For Pricewaterhousecoopers Llp As Biogen Inc.'S Independent Registered Public Accounting Firm For The Fiscal Year Ending December 31, 2017. 13 Say On Pay - To Approve An Mgmt For For For Advisory Vote On Executive Compensation. 14 Say When On Pay - To Approve An Mgmt 1 Year 1 Year For Advisory Vote On The Frequency Of The Advisory Vote On Executive Compensation. Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document 15 To Approve The Biogen Inc.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    734 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us